Literature DB >> 29719102

Risk factors for hypertrophic burn scar pain, pruritus, and paresthesia development.

Yongqiang Xiao1, Yu Sun1, Banghui Zhu1, Kangan Wang1, Pengfei Liang2, Wenjun Liu3, Jinfeng Fu3, Shiqing Zheng1, Shichu Xiao1, Zhaofan Xia1.   

Abstract

Hypertrophic scar pain, pruritus, and paresthesia symptoms are major and particular concerns for burn patients. However, because no effective and satisfactory methods exist for their alleviation, the clinical treatment for these symptoms is generally considered unsatisfactory. Therefore, their risk factors should be identified and prevented during management. We reviewed the medical records of 129 postburn hypertrophy scar patients and divided them into two groups for each of three different symptoms based on the University of North Carolina "4P" Scar Scale: patients with scar pain requiring occasional or continuous pharmacological intervention (HSc pain, n = 75) vs. patients without such scar pain (No HSc pain, n = 54); patients with scar pruritus requiring occasional or continuous pharmacological intervention (HSc pruritus, n = 63) vs. patients without such scar pruritus (No HSc pruritus, n = 66); patients with scar paresthesia that influenced the patients' daily activities (HSc paresthesia, n = 31) vs. patients without such scar paresthesia (No HSc paresthesia, n = 98). Three multivariable logistic regression models were built, respectively, to identify the risk factors for hypertrophic burn scar pain, pruritus, and paresthesia development. Multivariable analysis showed that hypertrophic burn scar pain development requiring pharmacological intervention was associated with old age (odds ratio [OR] = 1.046; 95% confidence interval [CI], 1.011-1.082, p = 0.009), high body mass index (OR = 1.242; 95%CI, 1.068-1.445, p = 0.005), 2-5-mm-thick postburn hypertrophic scars (OR = 3.997; 95%CI, 1.523-10.487, p = 0.005), and 6-12-month postburn hypertrophic scars (OR = 4.686; 95%CI, 1.318-16.653, p = 0.017). Hypertrophic burn scar pruritus development requiring pharmacological intervention was associated with smoking (OR = 3.239; 95%CI, 1.380-7.603; p = 0.007), having undergone surgical operation (OR = 2.236; 95%CI, 1.001-4.998; p = 0.049), and firm scars (OR = 3.317; 95%CI, 1.237-8.894; p = 0.017). Finally, hypertrophic burn scar paresthesia development which affected the patients' daily activities was associated with age (OR = 1.038; 95%CI, 1.002-1.075; p = 0.040), fire burns (OR = 0.041; 95%CI, 0.005-0.366; p = 0.004, other burns vs. flame burns), and banding and contracture scars (OR = 4.705; 95%CI, 1.281-17.288, p = 0.020).
© 2018 by the Wound Healing Society.

Entities:  

Mesh:

Year:  2018        PMID: 29719102     DOI: 10.1111/wrr.12637

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  4 in total

1.  Are burns a chronic condition? Examining patient reported outcomes up to 20 years after burn injury-A Burn Model System National Database investigation.

Authors:  Cailin A Abouzeid; Audrey E Wolfe; Pengsheng Ni; Gretchen J Carrougher; Nicole S Gibran; Flora M Hammond; Radha Holavanahalli; Kara A McMullen; Kimberly Roaten; Oscar Suman; Barclay T Stewart; Steven Wolf; Ross Zafonte; Lewis E Kazis; Colleen M Ryan; Jeffrey C Schneider
Journal:  J Trauma Acute Care Surg       Date:  2022-01-25       Impact factor: 3.697

2.  Recognizing the long-term sequelae of burns as a chronic medical condition.

Authors:  B M Kelter; R Holavanahalli; O E Suman; C M Ryan; J C Schneider
Journal:  Burns       Date:  2019-11-09       Impact factor: 2.609

3.  Effects of multiple modes of UltraPulse fractional CO2 laser treatment on extensive scarring: a retrospective study.

Authors:  Xiaojing Ge; Yute Sun; Jing Lin; Fang Zhou; Gang Yao; Xin Su
Journal:  Lasers Med Sci       Date:  2021-08-26       Impact factor: 3.161

4.  Ablative fractional CO2 laser surgery improving sleep quality, pain and pruritus in adult hypertrophic scar patients: a prospective cohort study.

Authors:  Kaiyang Lv; Huazhen Liu; Haiting Xu; Caixia Wang; Shihui Zhu; Xiaozhen Lou; Pengfei Luo; Shichu Xiao; Zhaofan Xia
Journal:  Burns Trauma       Date:  2021-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.